Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
주식 순위 #28845
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
주가
$1.89
마지막 동기화: 2022-12-16
시가총액
$24.38M
변동 (1일)
8.62%
변동 (1년)
0.00%
국가
US
거래 Yumanity Therapeutics, Inc. (YMTX)

카테고리

Yumanity Therapeutics, Inc. (YMTX)의 주식 분할 이력
Yumanity Therapeutics, Inc. 주식 (심볼: YMTX)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 19, 2026에 발생했습니다.
Aug 19, 2026 이전에 매수한 YMTX 주식 1주는 현재 0주의 YMTX 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH